...
prok-img

ProKidney Corp., Common Stock

PROK

NAQ

$1.51

+$0.05

(3.42%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.81B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.23M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.30
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.18 L
$4.44 H
$1.51

About ProKidney Corp., Common Stock

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePROKSectorS&P500
1-Week Return-15.88%-2.12%-3%
1-Month Return-8.48%-3.42%-0.73%
3-Month Return-38.62%-11.13%2.87%
6-Month Return-41.02%-5.74%7.17%
1-Year Return-15.64%3.97%25.31%
3-Year Return-84.7%1.05%28.38%
5-Year Return-85.06%34.37%81.89%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue--1.98M3.04M3.17M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":62.61,"profit":true},{"date":"2022-12-31","value":95.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit--(1.98M)(3.04M)(3.17M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-198400000,"profit":false},{"date":"2022-12-31","value":-303600000,"profit":false},{"date":"2023-12-31","value":-316900000,"profit":false}]
Gross Margin--(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses79.38M27.02M55.11M153.01M151.52M[{"date":"2019-12-31","value":51.88,"profit":true},{"date":"2020-12-31","value":17.66,"profit":true},{"date":"2021-12-31","value":36.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.03,"profit":true}]
Operating Income(19.16M)(27.02M)(55.11M)(153.01M)(151.52M)[{"date":"2019-12-31","value":-1915900000,"profit":false},{"date":"2020-12-31","value":-2702400000,"profit":false},{"date":"2021-12-31","value":-5511000000,"profit":false},{"date":"2022-12-31","value":-15300700000,"profit":false},{"date":"2023-12-31","value":-15152200000,"profit":false}]
Total Non-Operating Income/Expense-86.00K4.00K11.54M43.27M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.2,"profit":true},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":26.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(79.25M)(26.98M)(55.11M)(147.24M)(129.45M)[{"date":"2019-12-31","value":-7925400000,"profit":false},{"date":"2020-12-31","value":-2698100000,"profit":false},{"date":"2021-12-31","value":-5510800000,"profit":false},{"date":"2022-12-31","value":-14723900000,"profit":false},{"date":"2023-12-31","value":-12945100000,"profit":false}]
Income Taxes361.00K(232.00K)38.00K896.00K6.00M[{"date":"2019-12-31","value":6.02,"profit":true},{"date":"2020-12-31","value":-3.87,"profit":false},{"date":"2021-12-31","value":0.63,"profit":true},{"date":"2022-12-31","value":14.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(26.75M)(55.15M)(148.13M)(135.45M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2674900000,"profit":false},{"date":"2021-12-31","value":-5514600000,"profit":false},{"date":"2022-12-31","value":-14813500000,"profit":false},{"date":"2023-12-31","value":-13544700000,"profit":false}]
Income From Continuous Operations-(26.75M)(55.15M)(148.13M)(138.30M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2674900000,"profit":false},{"date":"2021-12-31","value":-5514600000,"profit":false},{"date":"2022-12-31","value":-14813500000,"profit":false},{"date":"2023-12-31","value":-13829600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(79.61M)(26.75M)(55.15M)(148.13M)(35.47M)[{"date":"2019-12-31","value":-7961500000,"profit":false},{"date":"2020-12-31","value":-2674900000,"profit":false},{"date":"2021-12-31","value":-5514600000,"profit":false},{"date":"2022-12-31","value":-14813500000,"profit":false},{"date":"2023-12-31","value":-3546800000,"profit":false}]
EPS (Diluted)--(0.08)(0.42)(0.57)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-8,"profit":false},{"date":"2022-12-31","value":-41.58,"profit":false},{"date":"2023-12-31","value":-57,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PROK
Cash Ratio 16.16
Current Ratio 17.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PROK
ROA (LTM) -20.37%
ROE (LTM) -31.34%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PROK
Debt Ratio Lower is generally better. Negative is bad. 0.07
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -2.06

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PROK
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 91.32
Price/FCF NM
EV/R 0.00
EV/Ebitda 2.13

FAQs

What is ProKidney Corp. share price today?

ProKidney Corp. (PROK) share price today is $1.51

Can Indians buy ProKidney Corp. shares?

Yes, Indians can buy shares of ProKidney Corp. (PROK) on Vested. To buy ProKidney Corp. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PROK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ProKidney Corp. be purchased?

Yes, you can purchase fractional shares of ProKidney Corp. (PROK) via the Vested app. You can start investing in ProKidney Corp. (PROK) with a minimum investment of $1.

How to invest in ProKidney Corp. shares from India?

You can invest in shares of ProKidney Corp. (PROK) via Vested in three simple steps:

  • Click on Sign Up or Invest in PROK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ProKidney Corp. shares
What is ProKidney Corp. 52-week high and low stock price?

The 52-week high price of ProKidney Corp. (PROK) is $4.44. The 52-week low price of ProKidney Corp. (PROK) is $1.18.

What is ProKidney Corp. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ProKidney Corp. (PROK) is

What is ProKidney Corp. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ProKidney Corp. (PROK) is 91.32

What is ProKidney Corp. dividend yield?

The dividend yield of ProKidney Corp. (PROK) is 0.00%

What is the Market Cap of ProKidney Corp.?

The market capitalization of ProKidney Corp. (PROK) is $1.81B

What is ProKidney Corp.’s stock symbol?

The stock symbol (or ticker) of ProKidney Corp. is PROK

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top